Study of CRLX101 (Formerly Named IT-101) in the Treatment of Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00333502
Recruitment Status : Completed
First Posted : June 5, 2006
Last Update Posted : April 20, 2017
Information provided by (Responsible Party):
NewLink Genetics Corporation